Enlivex Therapeutics Ltd. (ENLV) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ENLV is $15.00, representing a +1,772.7% upside from the current price of $0.801. Price targets range from a low of $15.00 to a high of $15.00.
